Back to User profile » Ms Priyanka Kulkarni
Papers published by Ms Priyanka Kulkarni:
Perspectives
Net Present Value Impact of FDA’s Phase 3 Waivers on Monoclonal Antibody Biosimilar Development
Ranbhor R, Kulkarni P
Biologics: Targets and Therapy 2026, 20:581013
Published Date: 10 February 2026
Original Research
Evaluating Biosimilar Development Projects: An Analytical Framework Utilizing Net Present Value
Ranbhor R, Kulkarni P
Biologics: Targets and Therapy 2025, 19:125-135
Published Date: 25 March 2025